受强制性开放获取政策约束的文章 - Anne Galy了解详情
无法在其他位置公开访问的文章：6 篇
Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia
P Rio, S Navarro, W Wang, R Sanchez-Dominguez, RM Pujol, ...
Nature medicine 25 (9), 1396-1401, 2019
强制性开放获取政策： Government of Spain
Lentiviral-mediated gene therapy in Fanconi anemia-A mice reveals long-term engraftment and continuous turnover of corrected HSCs
F Javier Molina-Estevez, A Nowrouzi, ML Lozano, A Galy, S Charrier, ...
Current gene therapy 15 (6), 550-562, 2015
强制性开放获取政策： Government of Spain
Toward a scalable purification protocol of GaLV-TR-pseudotyped lentiviral vectors
D Boudeffa, B Bertin, A Biek, M Mormin, F Leseigneur, A Galy, OW Merten
Human Gene Therapy Methods 30 (5), 153-171, 2019
强制性开放获取政策： National Institute of Health and Medical Research, France, European Commission
Lymphopoiesis in transgenic mice over-expressing Artemis
P Rivera-Munoz, V Abramowski, S Jacquot, P André, S Charrier, ...
Gene Therapy 23 (2), 176-186, 2016
强制性开放获取政策： National Institute of Health and Medical Research, France, European Commission
Recent advances in hematopoietic gene therapy for genetic disorders
A Galy, M Dewannieux
Archives de Pédiatrie 30 (8), 8S24-8S31, 2023
强制性开放获取政策： Agence Nationale de la Recherche
Cyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease
M Mormin, L Rigonnot, A Chalumeau, A Miccio, C Fournier, ...
Human Gene Therapy 35 (21-22), 896-903, 2024
强制性开放获取政策： Agence Nationale de la Recherche
可在其他位置公开访问的文章：46 篇
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome
A Aiuti, L Biasco, S Scaramuzza, F Ferrua, MP Cicalese, C Baricordi, ...
Science 341 (6148), 1233151, 2013
强制性开放获取政策： US National Institutes of Health, Fondazione Telethon, Italy, Government of …
Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors
U Modlich, S Navarro, D Zychlinski, T Maetzig, S Knoess, MH Brugman, ...
Molecular Therapy 17 (11), 1919-1928, 2009
强制性开放获取政策： US National Institutes of Health, German Research Foundation
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome
SHB Abina, HB Gaspar, J Blondeau, L Caccavelli, S Charrier, K Buckland, ...
Jama 313 (15), 1550-1563, 2015
强制性开放获取政策： US National Institutes of Health, National Institute of Health and Medical …
Gene therapy on the move
KB Kaufmann, H Büning, A Galy, A Schambach, M Grez
EMBO molecular medicine 5 (11), 1642-1661, 2013
强制性开放获取政策： German Research Foundation
Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application
OW Merten, S Charrier, N Laroudie, S Fauchille, C Dugué, C Jenny, ...
Human gene therapy 22 (3), 343-356, 2011
强制性开放获取政策： Fondazione Telethon, Italy
Lentiviral gene therapy for X-linked chronic granulomatous disease
DB Kohn, C Booth, EM Kang, SY Pai, KL Shaw, G Santilli, M Armant, ...
Nature medicine 26 (2), 200-206, 2020
强制性开放获取政策： US National Institutes of Health, National Institute for Health Research, UK …
Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes
M Khoury, V Escriou, G Courties, A Galy, R Yao, C Largeau, D Scherman, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2008
强制性开放获取政策： National Institute of Health and Medical Research, France
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult
EC Morris, T Fox, R Chakraverty, R Tendeiro, K Snell, C Rivat, S Grace, ...
Blood, The Journal of the American Society of Hematology 130 (11), 1327-1335, 2017
强制性开放获取政策： US National Institutes of Health, Fondazione Telethon, Italy, UK Medical …
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome
A Magnani, M Semeraro, F Adam, C Booth, L Dupré, EC Morris, ...
Nature medicine 28 (1), 71-80, 2022
强制性开放获取政策： Fondazione Telethon, Italy, National Institute for Health Research, UK …
Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programs
E Six, A Guilloux, A Denis, A Lecoules, A Magnani, R Vilette, F Male, ...
Blood 135 (15), 1219-1231, 2020
强制性开放获取政策： US National Institutes of Health, National Institute of Health and Medical …
Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients
P Río, S Navarro, G Guenechea, R Sánchez-Domínguez, ML Lamana, ...
Blood, The Journal of the American Society of Hematology 130 (13), 1535-1542, 2017
强制性开放获取政策： Government of Spain
Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells
F Benjelloun, A Garrigue, C Demerens-de Chappedelaine, ...
Molecular Therapy 16 (8), 1490-1499, 2008
强制性开放获取政策： National Institute of Health and Medical Research, France
Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting
J Tolar, JE Adair, M Antoniou, CC Bartholomae, PS Becker, BR Blazar, ...
Molecular Therapy 19 (7), 1193-1198, 2011
强制性开放获取政策： US National Institutes of Health, German Research Foundation
Lineage-and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease
I Barde, E Laurenti, S Verp, M Wiznerowicz, S Offner, A Viornery, A Galy, ...
Gene therapy 18 (11), 1087-1097, 2011
强制性开放获取政策： Swiss National Science Foundation
出版信息和资助信息由计算机程序自动确定